Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

214 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Active, Not Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

NCT05283720

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations
  • The University of Arizona Cancer Center - North Campus /ID# 242219 Tucson, Arizona, United States
  • Yale University School of Medicine /ID# 242089 New Haven, Connecticut, United States
  • Christiana Care Health Service /ID# 242301 Newark, Delaware, United States
  • Tampa General Hospital /ID# 246748 Tampa, Florida, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies

NCT05207670

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

A Rollover Study of CC-122

NCT05688475

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Local Institution - 100 New York, United States
  • Local Institution - 101 Nashville, Tennessee, United States
  • Local Institution - 102 Madison, Wisconsin, United States
  • Local Institution - 300 Bordeaux, France
View Trial Details
Active, Not Recruiting

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT05171647

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • St. Luke's Hospital Chesterfield, Missouri, United States
  • Ascension Seton Infusion Center Austin, Texas, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

DS-3201b in Participants With Lymphomas

NCT02732275

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope National Medical center Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details

Related conditions